Showing 641 - 660 results of 1,793 for search '"HIV"', query time: 0.08s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645
  6. 646
  7. 647
  8. 648
  9. 649
  10. 650

    Open Secret : people facing up to HIV and AIDS in Uganda /

    Published 2000
    View in OPAC
    Book
  11. 651
  12. 652

    The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa by Honoré Kalombayi Tshamala, Loukia Aketi, Pierre Manianga Tshibassu, Mathilde Bothale Ekila, Eric Musalu Mafuta, Patrick Kalambayi Kayembe, Michel Ntetani Aloni, Joseph Diayisu Shiku

    Published 2019-01-01
    “…Despite the high prevalence of the HIV/AIDS, few studies focused on the prevalence of lipodystrophy in pediatric HIV patients on antiretroviral therapy (ARV) in sub-Saharan African countries. …”
    Get full text
    Article
  13. 653

    Specific Antibody Production by Blood B Cells is Retained in Late Stage Drug-naïve HIV-infected Africans by Lydie Béniguel, Evelyne Bégaud, Fabrice Cognasse, Philippe Gabrié, Christophe D. Mbolidi, Mary A. Marovich, Céline Cazorla, Frédéric Lucht, Christian Genin, Olivier Garraud

    Published 2004-01-01
    “…The in vitro antibody production by drug-naïve individuals' PBMCs depended on exogenous cytokines (IL-2 and IL-10) but neither on the re-stimulation of reactive cells in cultures by purified HIV-1-gp 160 antigen nor on the re-engagement of CD40 surface molecules. …”
    Get full text
    Article
  14. 654
  15. 655

    Child-Centred Care in HIV Service Provision for Children in Resource Constrained Settings: A Narrative Review of Literature by Chipo Mutambo, Kemist Shumba, Khumbulani W. Hlongwana

    Published 2019-01-01
    “…Child-centred care approaches are increasingly gaining traction in healthcare; and are being applied in the delivery of HIV care for children in resource constrained settings. …”
    Get full text
    Article
  16. 656

    Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon by Emmanuel Armand Kouotou, Jobert Richie Nansseu, Vanessa Nancy Ngono, Sandra A. Tatah, Anne Cecile Zoung-Kanyi Bissek, Elie Claude Ndjitoyap Ndam

    Published 2017-01-01
    “…Prevalence and incidence of drug eruptions vary around the world and are influenced by some key factors including HIV infection. Objective. This study aimed to find the peculiarities of drug eruptions in people living with HIV (PLHIV) and on antiretroviral therapy (ART). …”
    Get full text
    Article
  17. 657

    Numerical Treatment of the Model for HIV Infection of CD4+T Cells by Using Multistep Laplace Adomian Decomposition Method by Nurettin Doğan

    Published 2012-01-01
    “…A new method for approximate analytic series solution called multistep Laplace Adomian Decomposition Method (MLADM) has been proposed for solving the model for HIV infection of CD4+T cells. The proposed method is modification of the classical Laplace Adomian Decomposition Method (LADM) with multistep approach. …”
    Get full text
    Article
  18. 658

    Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings by Wirach Maek-a-Nantawat, Anchalee Avihingsanon, Pirapon June Ohata

    Published 2012-01-01
    “…Hepatitis B and C infections are prevalent among HIV-infected individuals with different epidemiologic profiles, modes of transmission, natural histories, and treatments. …”
    Get full text
    Article
  19. 659

    Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients by Glenn Wagner, Karen Chan Osilla, Jeffrey Garnett, Bonnie Ghosh-Dastidar, Laveeza Bhatti, Matthew Bidwell Goetz, Mallory Witt

    Published 2011-01-01
    “…Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the psychosocial determinants of treatment adherence and outcomes. …”
    Get full text
    Article
  20. 660

    Risk Factors Associated with False Positive HIV Test Results in a Low-Risk Urban Obstetric Population by Tamara T. Chao, Jeanne S. Sheffield, George D. Wendel, M. Qasim Ansari, Donald D. McIntire, Scott W. Roberts

    Published 2012-01-01
    “…To examine risk factors for false positive HIV enzyme immunoassay (EIA) testing at delivery. …”
    Get full text
    Article